Related Experiment Video

Updated: Sep 3, 2026

A Screenable In Vivo Assay for Mitochondrial Modulators Using Transgenic Bioluminescent Caenorhabditis elegans
11:43

A Screenable In Vivo Assay for Mitochondrial Modulators Using Transgenic Bioluminescent Caenorhabditis elegans

Published on: October 16, 2015

The mutagenic activity of quinacrine hydrochloride in the silkworm

A Murakami

    Mutation Research
    |March 1, 1974
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Embryo Microinjection Techniques for Efficient Site-Specific Mutagenesis in Culex quinquefasciatus
    05:59

    Embryo Microinjection Techniques for Efficient Site-Specific Mutagenesis in Culex quinquefasciatus

    Published on: May 24, 2020

    Developing a Feeding Assay System for Evaluating the Insecticidal Effect of Phytochemicals on Helicoverpa armigera
    04:51

    Developing a Feeding Assay System for Evaluating the Insecticidal Effect of Phytochemicals on Helicoverpa armigera

    Published on: May 26, 2023

    Related Experiment Videos

    Last Updated: Sep 3, 2026

    A Screenable In Vivo Assay for Mitochondrial Modulators Using Transgenic Bioluminescent Caenorhabditis elegans
    11:43

    A Screenable In Vivo Assay for Mitochondrial Modulators Using Transgenic Bioluminescent Caenorhabditis elegans

    Published on: October 16, 2015

    Embryo Microinjection Techniques for Efficient Site-Specific Mutagenesis in Culex quinquefasciatus
    05:59

    Embryo Microinjection Techniques for Efficient Site-Specific Mutagenesis in Culex quinquefasciatus

    Published on: May 24, 2020

    Developing a Feeding Assay System for Evaluating the Insecticidal Effect of Phytochemicals on Helicoverpa armigera
    04:51

    Developing a Feeding Assay System for Evaluating the Insecticidal Effect of Phytochemicals on Helicoverpa armigera

    Published on: May 26, 2023

    Related Concept Videos

    Mutagenicity and Carcinogenicity01:25

    Mutagenicity and Carcinogenicity

    Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

    Articles linked to this work by shared authors, journal, and citation graph.

    All-trans-retinoic acid inhibits tumour growth of malignant pleural mesothelioma in mice.

    The European respiratory journal·2009

    Characterization of monoclonal antibodies directed against squamous cell carcinoma antigens: report of the second TD-10 workshop.

    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine·2009

    [Risk management for congenital heart surgery].

    Kyobu geka. The Japanese journal of thoracic surgery·2008

    NOTES transvaginal video-assisted cholecystectomy: first series.

    Endoscopy·2008

    Depositional records of plutonium and (137)Cs released from Nagasaki atomic bomb in sediment of Nishiyama reservoir at Nagasaki.

    Journal of environmental radioactivity·2008

    Observation of time-dependent CP violation in B0 --> eta'K0 decays and improved measurements of CP asymmetries in B0 --> phiK0, KS0KS0KS0 and B0 --> J/psiK0 decays.

    Physical review letters·2007

    A crosslinking positive control for any in vivo comet assay tissue.

    Mutation research·2026

    Molecular characterisation and mutational analysis of antimicrobial resistance genes in Helicobacter pylori isolates in Erbil, Iraq.

    Mutation research·2026

    In silico analysis of missense variants in functional domains of PWWP2A and PWWP2B proteins.

    Mutation research·2026

    The role of KIT mutations in oral melanoma and disease progression: A literature review on early detection and targeted therapy.

    Mutation research·2026

    Mothers against decapentaplegic homolog 3-activated FAT atypical cadherin 2 regulates programmed death ligand-1 to mediate immune evasion in lung squamous cell carcinoma.

    Mutation research·2026

    Potential targets and molecular mechanisms of curcumin in treating Laryngeal and Pharyngeal Carcinoma throat cancer based on network pharmacology and bioinformatics analysis.

    Mutation research·2026

    Covalent allosteric inhibition of AARS1 lactyltransferase.

    Nature communications·2026

    Discovery of D-peptides that allosterically enhance SARS-CoV-2 3CLpro activity by stabilizing its monomeric state.

    Protein science : a publication of the Protein Society·2026

    Optimization of the Isolation and Purification of Formononetin from Lycopus lucidus Turcz. var. hirtus Regel, Structural Identification, and Its In Vitro Anti-Inhibitory Effects in TNF-α-Induced HFLS-RA Cells.

    Plants (Basel, Switzerland)·2026

    Agonist Binding Reshapes the Kinetic Landscape and Allosteric Communication of APLNR Toward Activation-Competent States.

    International journal of molecular sciences·2026

    Optimization of the preparation of Gastrodia elata polysaccharide and investigation of their immunostimulatory activity in mice.

    Ultrasonics sonochemistry·2026

    The insect effector CSPs activate an atypical plant TNL immune receptor.

    Plant cell reports·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us